Opus Genetics, Inc. (IRD) Misses Q1 EPS by 62c
Tweet
Share
E-mailGet Alerts IRD Hot Sheet
Join SI Premium – FREE
Opus Genetics, Inc. (NASDAQ: IRD) reported Q1 EPS of ($0.75), $0.62 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $2.16 million versus the consensus estimate of $3.16 million.
For earnings history and earnings-related data on Opus Genetics, Inc. (IRD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jack Henry (JKHY) Tops Q4 EPS by 13c
- Evolution Petroleum to buy Midland Basin mineral rights for $16M
- Freedom Broker Downgrades Flexsteel (FLXS) to Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
